Vdr expression in osteoclast precursors is not critical in bone homeostasis
- 1 December 2019
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 195, 105478
Abstract
No abstract availableKeywords
Funding Information
- University of Leuven (C16/18/006)
- Research Foundation–Flanders (G0D4217N-FB)
This publication has 21 references indexed in Scilit:
- Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanismsBoneKEy Reports, 2014
- Identification of the Vitamin D Receptor in Osteoblasts and Chondrocytes But Not Osteoclasts in Mouse BoneJournal of Bone and Mineral Research, 2013
- Nrp2 deficiency leads to trabecular bone loss and is accompanied by enhanced osteoclast and reduced osteoblast numbersBone, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D–induced inhibition of bone mineralizationJournal of Clinical Investigation, 2012
- Guidelines for assessment of bone microstructure in rodents using micro–computed tomographyJournal of Bone and Mineral Research, 2010
- Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblastsJournal of Clinical Investigation, 2006
- Mice Lacking the Plasminogen Activator Inhibitor 1 Are Protected from Trabecular Bone Loss Induced by Estrogen DeficiencyJournal of Bone and Mineral Research, 2000
- Stimulation of Osteoclast Formation by 1,25-Dihydroxyvitamin D Requires Its Binding to Vitamin D Receptor (VDR) in Osteoblastic Cells: Studies Using VDR Knockout MiceEndocrinology, 1999
- Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro1Endocrinology, 1998